The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF

American Journal of Kidney Diseases

Volumn 44, Issue 1, 2004, Pages 77-83

  Svensson, My ^a   Christensen, Jeppe Hagstrup ^b   Sølling, Jakob ^b   Schmidt, Erik Berg ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

cardiovascular disease (CVD); Chronic renal failure (CRF); lipids; n 3 polyunsaturated fatty acid (PUFA)

Indexed keywords

CALCIUM ANTAGONIST; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLIVE OIL; OMEGA 3 FATTY ACID; STATIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GASTROINTESTINAL SYMPTOM; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TISSUE SLICE;

ADIPOSE TISSUE; ANTILIPEMIC AGENTS; CHOLESTEROL, HDL; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 3042817602     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.03.024     Document Type: Article

References (47)

1. Levin A., Foley R. Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis. 36:(suppl 3):2000;S24-S30
2. Levey A., Beto J., Coronado B., et al. Controlling the epidemic of cardiovascular disease in chronic renal disease What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis. 32:1998;853-906
3. Garg A.X., Clark W.F., Haynes B., House A.A. Moderate renal insufficiency and the risk of cardiovascular mortality Results from the NHANES 1. Kidney Int. 61:2002;1486-1494
4. Longenecker J.C., Coresh J., Powe N.R., et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population The CHOICE study. J Am Soc Nephrol. 13:2002;1918-1927
5. Koenig W. Update on C-reactive protein as a risk marker in cardiovascular disease. Kidney Int Suppl. 84:2003;S58-S61
6. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis. 41:(suppl 3):2003;S8-S58
7. Deighan C., Caslake M., McConnell M., Boulton-Jones J.M., Packard C. Atherogenic lipoprotein phenotype in end-stage renal failure Origin and extent of small dense low-density lipoprotein formation. Am J Kidney Dis. 35:2000;852-862
8. Rajman I., Harper L., McPake D., Kendall M., Wheeler D. Low-density lipoprotein subfraction profiles in chronic renal failure. Nephrol Dial Transplant. 13:1998;2281-2287
9. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease. AHA scientific statement. Circulation. 108:2003;2154-2169
10. Burr M.L., Feihly A.M., Gilbert J.F., et al. Effects of changes in fat, fish and fibre intakes on death and myocardial infarction; Diet and Reinfarction Trial (DART). Lancet. 30:1989;757-761
11. GISSI Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction; Results of the GISSI Prevenzione trial. Lancet. 354:1999;447-455
12. Kris-Etherton P., Harris W., Appel L. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids and cardiovascular disease. Circulation. 106:2002;2747-2757
13. Daviglus M., Stamler J., Orencia A., et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 336:1997;1046-1053
14. Siscovick D., Raghunathan T.E., King I., et al. Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr. 71:2000;208-212
15. Albert C., Campos H., Stampfer M., et al. Blood levels of long chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 346:2002;113-118
16. Christensen J.H. n-3 Fatty acids and the risk of sudden cardiac death Emphasis on heart variability. Dan Med Bull. 50:2003;347-367
17. Harris W.S. n-3 Fatty acids and serum lipoproteins Human studies. Am J Clin Nutr. 65:(suppl 5):1997;S1645-S1654
18. Schmidt E.B. n-3 Fatty acids and the risk of coronary heart disease. Dan Med Bull. 44:1997;1-22
19. Appel L., Miller E., Seidler A., Whelton P. Does supplementation of diet with fish oil reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med. 153:1993;1429-1438
20. Morris M., Sacks F., Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation. 88:1993;523-533
21. Geleijnse J., Giltay E., Grobbee D., et al. Blood pressure response to fish oil supplementation Metaregression analysis of randomised trials. J Hypertens. 20:2002;1493-1499
22. Christensen J.H., Skou H.A., Fog L., et al. Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation. 103:2001;651-657
23. Beynen A.C., Katan M.B. Rapid sampling and long-time storage of subcutaneous adipose-tissue biopsies for determination of fatty acid composition. Am J Clin Nutr. 42:1985;317-322
24. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 37:1959;911-917
25. Christoffersen S.W., Glass R.L. Preparation of milk fat methyl esters by alcoholysis in an essentially non-alcoholic solution. J Dairy Sci. 52:1969;1289-1290
26. Austin M., Hokanson J., Edwards K. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 81:1998;7B-12B
27. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Circulation. 106:2002;3143-3421
28. Sarnak M.J., Coronado B.E., Greene T., et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol. 57:2002;327-335
29. Uhlig K., Levey A., Sarnak M. Traditional risk factors in individuals with chronic kidney disease. Semin Dial. 16:2003;118-127
30. Azar R., Dequiedt F., Awada J., Dequiedt P., Tacquet A. Effects of fish oil rich in polyunsaturated fatty acids on hyperlipemia of hemodialysis patients. Kidney Int Suppl. 27:1989;S239-S242
31. Rolf N., Tenschert W., Lison A.E. Results of long-term administration of omega-3 fatty acids in hemodialysis patients with dyslipoproteinaemia. Nephrol Dial Transplant. 5:1990;797-801
32. Khajedi P. Lipid-lowering effect of polyunsaturated fatty acids in hemodialysis patients. J Ren Nutr. 10:2000;191-195
33. Nordøy A. Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease. Minerva Med. 93:2002;357-363
34. Lowrie E.G., Lew N.L. Death risk in hemodialysis patients The predictive rate of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 15:1990;458-482
35. Iseki K., Yamazato M., Tozawa M., Takashita S. Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int. 61:2002;1887-1893
36. Baigent C., Landry M. Study of Heart and Renal Protection (SHARP). Kidney Int Suppl. 84:2003;S207-S210
37. Holdaas H., Fellstrøm B., Jardine A., et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients A multicentre, randomised, placebo-controlled trial. Lancet. 361:2003;2024-2031
38. Craig W.Y., Neveux L.M., Palomaki G.E., Cleveland M.M., Haddow J.E. Lipoprotein(a) as a risk factor for ischemic heart disease Metaanalysis of prospective studies. Clin Chem. 44:1998;2301-2306
39. Danesh J., Collins R., Peto R. Lipoprotein(a) and coronary heart disease. Circulation. 102:2000;1082-1085
40. Zimermann J., Herrlinger S., Pruy A., Metzger T., Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 55:1999;648-658
41. Lungerhausen Y., Abbey M., Nestel P., Howe P. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J Hypertens. 12:1994;1041-1045
42. Singer P., Melzer S., Goschel M., Augustin S. Fish oil amplifies the effect of propranolol in mild essential hypertension. Hypertension. 16:1990;682-691
43. Russo C., Olivieri O., Girelli D., et al. Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension. J Hypertens. 13:1995;1823-1826
44. Bao D.Q., Mori T.A., Burke V., Puddey I.B., Bellin L.J. Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension. 32:1998;710-717
45. Donadio J. n-3 Fatty acids and their role in nephrologic practice. Curr Opin Nephrol. 10:2001;639-642
46. De Caterina R., Endres S., Kristensen S.D., Schmidt E.B. n-3 Fatty acids and renal diseases. Am J Kidney Dis. 24:1994;397-415
47. Kutner N.G., Clow P.W., Zhang R., Aviles X. Association of fish intake and survival in a cohort of incident dialysis patients. Am J Kidney Dis. 39:2002;1018-1024